Targeting a specific enzyme to improve recovery after brain injuries
Therapeutic Targeting of Monoacylglycerol Lipase After Traumatic Brain Injury
This study is looking at how a specific enzyme might help reduce swelling and improve healing for people who have had a traumatic brain injury, by using natural compounds in the body that help balance the immune system.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10842448 on NIH RePORTER |
What this research studies
This research investigates how targeting the enzyme monoacylglycerol lipase (MAGL) can help reduce inflammation and improve recovery in patients who have suffered a traumatic brain injury (TBI). The study focuses on the role of endocannabinoids, which are natural compounds in the body that can help restore balance in the immune system and reduce swelling in the brain. By understanding how MAGL affects these processes, the research aims to develop new therapeutic strategies that could enhance patient outcomes following TBI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently suffered a traumatic brain injury.
Not a fit: Patients with chronic brain injuries or those who do not have a recent history of traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved recovery and reduced long-term disabilities for patients who experience traumatic brain injuries.
How similar studies have performed: Previous research has shown promising results in using endocannabinoids to improve outcomes after brain injuries, indicating that this approach may be effective.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Vaibhav, Kumar — Augusta University
- Study coordinator: Vaibhav, Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.